The latest market report published by
Credence Research, Inc. “Global Neurofeedback
Systems Market By Type (Frequency Neurofeedback System, Low Energy
Neurofeedback System, Slow Cortical Potential Neurofeedback System,
Hemoencephalographic Neurofeedback System, Low Resolution Electromagnetic
Tomography and Functional Magnetic Resonance Imaging (fMRI)), By Application
(Attention Deficit Hyperactivity Disorder (ADHD), Epilepsy, Anxiety, Insomnia,
Migraine, Drug Addiction and Others) - Growth, Future Prospects &
Competitive Analysis, 2018 – 2026,” the global neurofeedback systems
market was valued at US$ 820.7 Mn in 2017, and is expected to reach US$ 1,565.6
Mn by 2026, expanding at a CAGR of 7.5% from 2018 to 2026.
Browse the full report Neurofeedback Systems Market - Growth,
Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/neurofeedback-systems-market
Market Insights:
Neurological disorder is the
electrical or biochemical abnormality of the human nervous system. The specific
causes ranges from congenital abnormalities, genetic, lifestyle disorders to
brain injury. Neurofeedback systems has been recognized as the most effective
alternative treatment option for brain abnormalities. It is highly effective in
patients showing non-compliance and resistance to medicine therapy.
In the present scenario frequency
neurofeedback system is reigning the type segment for neurofeedback systems. It
employs 2 to 4 surface electrodes and is popularly known as surface
neurofeedback system. High degree of simplicity, ease of operation and
popularity among neurologists drive the frequency neurofeedback systems market
growth. Functional magnetic resonance imaging (fMRI) is the latest
neurofeedback system which is successful in modulating brain activity in the
deep subcortical brain region. It is used during epileptic surgical procedures
by neurologists.
Currently 50 million people throughout
the globe are suffering with epilepsy making it the most common neurological
disease worldwide as published by Global Disease Burden (GDB) in Lancet
journal. In epilepsy the human brain continuously misfires signals, hence
neurofeedback systems modulate the brain by inhibiting slow waves and promoting
mid-range frequency waves eventually preventing seizures. ADHD has been popular
in the last decade owing to the severe adverse effects associated with its long
term medication such as insomnia, anxiety and loss of appetite. Neurofeedback
systems has been successful in treating ADHD by decreasing brain activity in
theta band region and promoting activity in beta band region.
North America currently represents a
share of 60% and is the largest regional market in global neurofeedback systems
market. Rising prevalence of neurological disease and existence of advanced
healthcare infrastructure drive the neurofeedback systems market growth in
North America region. Europe with a share of 20% is the second largest market
owing to increasing number of patients suffering with insomnia and anxiety.
Asia Pacific currently holds 8% market share and is on the path to register
impressive growth in the near future on account of developing healthcare
infrastructure and rampant growth in neurological disease diagnosis and
treatment.
Medical device manufacturers producing
EEG equipment for neurofeedback systems are BrainMaster Technologies, Inc., BEE
Medic GmbH, Mind Media B.V., Mitsar Co., Ltd., Myndlift, Neurobit Systems,
NeuroCare Group GmbH, Stens Corporation, Thought Technology Ltd. and Wearable
Sensing.
Key Market
Movements:
- Rising prevalence of neurological disease
- Increasing adoption of EEG biofeedback
system treatment in patients showing resistance to medications
- Technological advancement in EEG devices
with ability to determine brainwaves landscape and modulate them according
to neurological disease treatment
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59563
Table of Content
Chapter 1.
Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2.
Executive Summary
2.1. Global Neurofeedback Systems Market Portraiture
2.2. Global Neurofeedback Systems Market, by Type, 2017 (US$ Mn)
2.3. Global Neurofeedback Systems Market, by Application, 2017 (US$ Mn)
2.4. Global Neurofeedback Systems Market, by Geography, 2017 (US$ Mn)
2.1. Global Neurofeedback Systems Market Portraiture
2.2. Global Neurofeedback Systems Market, by Type, 2017 (US$ Mn)
2.3. Global Neurofeedback Systems Market, by Application, 2017 (US$ Mn)
2.4. Global Neurofeedback Systems Market, by Geography, 2017 (US$ Mn)
Chapter 3.
Neurofeedback Systems Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Neurofeedback Systems Market, by Key Players, 2017
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Neurofeedback Systems Market, by Key Players, 2017
Chapter 4. Global
Neurofeedback Systems Market, by Type
4.1. Overview
4.2. Frequency Neurofeedback System (FNS)
4.3. Low Energy Neurofeedback System (LENS)
4.4. Slow Cortical Potential Neurofeedback System (SCP-NF)
4.5. Hemoencephalographic Neurofeedback System (HEG)
4.6. Low Resolution Electromagnetic Tomography (LORE-TA)
4.7. Functional Magnetic Resonance Imaging (fMRI)
4.1. Overview
4.2. Frequency Neurofeedback System (FNS)
4.3. Low Energy Neurofeedback System (LENS)
4.4. Slow Cortical Potential Neurofeedback System (SCP-NF)
4.5. Hemoencephalographic Neurofeedback System (HEG)
4.6. Low Resolution Electromagnetic Tomography (LORE-TA)
4.7. Functional Magnetic Resonance Imaging (fMRI)
Chapter 5. Global
Neurofeedback Systems Market, by Application
5.1. Overview
5.2. Attention Deficit Hyperactivity Disorder (ADHD)
5.3. Epilepsy
5.4. Anxiety
5.5. Insomnia
5.6. Migraine
5.7. Drug Addiction
5.8. Others
5.1. Overview
5.2. Attention Deficit Hyperactivity Disorder (ADHD)
5.3. Epilepsy
5.4. Anxiety
5.5. Insomnia
5.6. Migraine
5.7. Drug Addiction
5.8. Others
Chapter 6. Global
Neurofeedback Systems Market, by Geography
6.1. Overview
6.2. North America Neurofeedback Systems Market Analysis, 2016 – 2026
6.2.1. North America Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America Neurofeedback Systems Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Neurofeedback Systems Market Analysis, 2016 – 2026
6.3.1. Europe Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Neurofeedback Systems Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Neurofeedback Systems Market Analysis, 2016 – 2026
6.5.1. Latin America Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa Neurofeedback Systems Market Analysis, 2016 – 2026
6.6.1. MEA Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
6.1. Overview
6.2. North America Neurofeedback Systems Market Analysis, 2016 – 2026
6.2.1. North America Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America Neurofeedback Systems Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Neurofeedback Systems Market Analysis, 2016 – 2026
6.3.1. Europe Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Neurofeedback Systems Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Neurofeedback Systems Market Analysis, 2016 – 2026
6.5.1. Latin America Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa Neurofeedback Systems Market Analysis, 2016 – 2026
6.6.1. MEA Neurofeedback Systems Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA Neurofeedback Systems Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA Neurofeedback Systems Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7.
Company Profiles
7.1. BrainMaster Technologies, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. BEE Medic GmbH
7.3. Mind Media B.V.
7.4. Mitsar Co., Ltd.
7.5. Myndlift
7.6. Neurobit Systems
7.7. NeuroCare Group GmbH
7.8. Stens Corporation.
7.9. Thought Technology Ltd.
7.10. Wearable Sensing.
7.1. BrainMaster Technologies, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. BEE Medic GmbH
7.3. Mind Media B.V.
7.4. Mitsar Co., Ltd.
7.5. Myndlift
7.6. Neurobit Systems
7.7. NeuroCare Group GmbH
7.8. Stens Corporation.
7.9. Thought Technology Ltd.
7.10. Wearable Sensing.
Do Inquiry before
buying research report: https://www.credenceresearch.com/inquiry-before-buying/59563
About Us
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we've manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290